Global Prenatal Genetic Testing—Forecast to 2026

Healthcare Global Prenatal Genetic Testing—Forecast to 2026

Innovation Culture in Screening Drives Prenatal Genetic Testing Growth and Makes it Accessible to More Patients

INDUSTRY
Healthcare
SECTOR
Life Sciences

RELEASE DATE
03-Oct-2022
REGION
Global
DELIVERABLE TYPE
Market Research

RESEARCH CODE
K7E9-01-00-00-00
SKU
HC03591-GL-MT_26963
Yes
SHARE

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC03591-GL-MT_26963

Global Prenatal Genetic Testing—Forecast to 2026
Published on: 03-Oct-2022 | SKU: HC03591-GL-MT_26963

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

New technological advances in prenatal genetic testing include the enhancement of the next-generation sequencing (NGS) technology, chromosomal microarray analysis (CMA) tool, and PCR TaqMan. These improve precision and specificity in genome profiling, augment the efficiency and reliability of testing, and streamline workflow.

The study will help prenatal genetic testing providers understand the key trends emerging in the market (for the various prenatal tests offered in different geographic regions). It provides information on the state of the market and estimates its growth for the next 5 years, and it lists the unmet needs that companies must work on for their continuous growth. In addition, the study provides an overview of the major vendors offering tests, their market concentration, and different growth strategies.

The research service guides prenatal genetic testing providers in mapping strategic priorities and developing new capabilities to capitalize on emerging growth opportunities in this market based on current and expected numbers.

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on Prenatal Genetic Testing

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Segmentation

Competitive Landscape: Regional Snapshot

Growth Metrics

Growth Drivers

Growth Restraints

Global Impact of Changes in the US Abortion Law

Forecast Assumptions

Revenue Forecast

Revenue Forecast by Type of Test

Revenue Forecast by Type of Test (continued)

Revenue Forecast by Type of Test (continued)

Revenue Forecast by Region

Revenue Forecast Analysis

Pricing Trends and Forecast Analysis

Competitive Environment

Revenue Share

Revenue Share Analysis

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

NIPT Market Overview

Growth Metrics

Revenue Forecast

Forecast Analysis

Carrier Screening Test Market Overview

Growth Metrics

Revenue Forecast

Forecast Analysis

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Invasive Tests Market Overview

Growth Metrics

Revenue Forecast

Forecast Analysis

Miscarriage Test Market Overview

Growth Metrics

Revenue Forecast

Forecast Analysis

Growth Opportunity 1: eCommerce and Direct-to-consumer Sales

Growth Opportunity 1: eCommerce and Direct-to-consumer Sales (continued)

Growth Opportunity 2: Technological Advancement and Low-Cost Solutions 

Growth Opportunity 2: Technological Advancement and Low-Cost Solutions (continued)

Growth Opportunity 3: Partnerships and Joint Ventures

Growth Opportunity 3: Partnerships and Joint Ventures (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

List of Exhibits (continued)

Legal Disclaimer

List of Figures
  • Prenatal Genetic Testing: Key Competitors by Region, Global, 2022
  • Prenatal Genetic Testing: Growth Metrics, Global, 2021
  • Prenatal Genetic Testing: Growth Drivers, Global, 2022–2026
  • Prenatal Genetic Testing: Growth Restraints, Global, 2022–2026
  • Prenatal Genetic Testing: Revenue Forecast, Global, 2021–2026
  • Prenatal Genetic Testing: Revenue Forecast by Type of Test, Global, 2021–2026
  • Prenatal Genetic Testing: Market Share Forecast by Type of Test, Global, 2021 and 2026
  • Prenatal Genetic Testing: Revenue Forecast by Region, 2021–2026
  • Prenatal Genetic Testing: Revenue Share of Top Participants, Global, 2021
  • Screening Tests: Growth Metrics, Global, 2021
  • Screening Tests: Revenue Forecast, Global, 2021–2026
  • Screening Tests: Revenue Forecast by Region, 2021–2026
  • NIPT: Growth Metrics, Global, 2021
  • NIPT: Revenue Forecast, Global, 2021–2026
  • Carrier Screening: Growth Metrics, Global, 2021
  • Carrier Screening: Revenue Forecast, Global, 2021–2026
  • Diagnostic Tests: Growth Metrics, Global, 2021
  • Diagnostic Tests: Revenue Forecast, Global, 2021–2026
  • Diagnostic Tests: Revenue Forecast by Region, 2021–2026
  • Invasive Test: Growth Metrics, Global, 2021
  • Invasive Test: Revenue Forecast, Global, 2021–2026
  • Miscarriage Test: Growth Metrics, Global, 2021
  • Miscarriage Test: Revenue Forecast, Global, 2021–2026

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Life Sciences research

13 Jan 2025   |   Global   |   Market Outlook

Top 6 Growth Opportunities for the Digital Health Industry, 2025

Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...

17 Dec 2024   |   Global   |   Market Research

Cybersecurity in Healthcare, United States, 2024

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...

12 Dec 2024   |   Global   |   Market Outlook

Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...

05 Dec 2024   |   Global   |   Frost Radar

Frost Radar™: Enterprise Conversational AI in Healthcare, 2024

This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-car...

27 Nov 2024   |   Global   |   Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

New technological advances in prenatal genetic testing include the enhancement of the next-generation sequencing (NGS) technology, chromosomal microarray analysis (CMA) tool, and PCR TaqMan. These improve precision and specificity in genome profiling, augment the efficiency and reliability of testing, and streamline workflow. The study will help prenatal genetic testing providers understand the key trends emerging in the market (for the various prenatal tests offered in different geographic regions). It provides information on the state of the market and estimates its growth for the next 5 years, and it lists the unmet needs that companies must work on for their continuous growth. In addition, the study provides an overview of the major vendors offering tests, their market concentration, and different growth strategies. The research service guides prenatal genetic testing providers in mapping strategic priorities and developing new capabilities to capitalize on emerging growth opportunities in this market based on current and expected numbers.
More Information
Deliverable Type Market Research
Author Lucila Martin
Industries Healthcare
No Index No
Is Prebook No
List of Charts and Figures Prenatal Genetic Testing: Key Competitors by Region, Global, 2022~ Prenatal Genetic Testing: Growth Metrics, Global, 2021~ Prenatal Genetic Testing: Growth Drivers, Global, 2022–2026~ Prenatal Genetic Testing: Growth Restraints, Global, 2022–2026~ Prenatal Genetic Testing: Revenue Forecast, Global, 2021–2026~ Prenatal Genetic Testing: Revenue Forecast by Type of Test, Global, 2021–2026~ Prenatal Genetic Testing: Market Share Forecast by Type of Test, Global, 2021 and 2026~ Prenatal Genetic Testing: Revenue Forecast by Region, 2021–2026~ Prenatal Genetic Testing: Revenue Share of Top Participants, Global, 2021~ Screening Tests: Growth Metrics, Global, 2021~ Screening Tests: Revenue Forecast, Global, 2021–2026~ Screening Tests: Revenue Forecast by Region, 2021–2026~ NIPT: Growth Metrics, Global, 2021~ NIPT: Revenue Forecast, Global, 2021–2026~ Carrier Screening: Growth Metrics, Global, 2021~ Carrier Screening: Revenue Forecast, Global, 2021–2026~ Diagnostic Tests: Growth Metrics, Global, 2021~ Diagnostic Tests: Revenue Forecast, Global, 2021–2026~ Diagnostic Tests: Revenue Forecast by Region, 2021–2026~ Invasive Test: Growth Metrics, Global, 2021~ Invasive Test: Revenue Forecast, Global, 2021–2026~ Miscarriage Test: Growth Metrics, Global, 2021~ Miscarriage Test: Revenue Forecast, Global, 2021–2026~
Podcast No
WIP Number K7E9-01-00-00-00